Hims & Hers Health Q1 Earnings, Revenue Rise

May 6, 2025

Intraday chart for Hims & Hers Health, Inc. 39.90 -4.72%
May. 05
Hims & Hers Health, Inc., Q1 2025 Earnings Call, May 05, 2025
May. 05
Hims & Hers Health Q1 Earnings, Revenue Rise
MT

Published on 05/05/2025 at 16:47

mtnewswires logo

© MT Newswires – 2025


Latest news about Hims & Hers Health, Inc.


Hims & Hers Health, Inc., Q1 2025 Earnings Call, May 05, 2025
May. 05

Hims & Hers Health Q1 Earnings, Revenue Rise
May. 05 MT

Hims & Hers Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025
May. 05 CI

Earnings Flash (HIMS) Hims & Hers Health Reports Q1 Revenue $586M, vs. FactSet Est of $538.6M
May. 05 MT

Hims & Hers Health, Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2025
May. 05 CI

Hims & Hers Health Names Nader Kabbani COO
May. 05 MT

Hims & Hers Appoints Nader Kabbani as Chief Operations Officer
May. 05 CI

Social Buzz: Wallstreetbets Stocks Mostly Lower Premarket Monday; Netflix, Strategy to Decline
May. 05 MT

Hims & Hers Health Insider Sold Shares Worth $3,077,070, According to a Recent SEC Filing
May. 01 MT

Social Buzz: Wallstreetbets Stocks Mostly Lower Premarket Wednesday; Super Micro Computer, Snap to Decline
Apr. 30 MT

US Equities Markets End Higher Tuesday Despite Soft Economic Data
Apr. 29 MT

Sector Update: Health Care Stocks Gain Late Afternoon
Apr. 29 MT

Sector Update: Health Care Stocks Higher Tuesday Afternoon
Apr. 29 MT

Novo Nordisk to sell Wegovy through telehealth firms to cash-paying US customers
Apr. 29 RE

Novo Nordisk to sell Wegovy through telehealth firms to cash-paying US customers
Apr. 29 RE

Novo Nordisk Partners With Hims to Sell Wegovy at Reduced Price; Shares Rise
Apr. 29 MT

Earnings-driven moves take STOXX 600 to sixth consecutive daily gain
Apr. 29 RE

Top Midday Stories: Amazon Says Listing Tariff Pricing Never Considered for Main Site; Novo Nordisk Partners With Hims on Wegovy
Apr. 29 MT

Sector Update: Health Care Stocks Flat to Lower Premarket Tuesday
Apr. 29 MT

Sector Update: Health Care
Apr. 29 MT

Novo Nordisk Partners with Hims to Sell Wegovy at Reduced Price
Apr. 29 MT

Hims & Hers, Novo Nordisk Team Up to Offer Weight-Loss Treatment Drugs
Apr. 29 DJ

Morgan Stanley Cuts Price Target on Hims & Hers Health to $40 From $60, Keeps Equalweight Rating
Apr. 29 MT

Novo Nordisk Partners With Hims to Sell Wegovy at Reduced Price, Bloomberg Reports
Apr. 29 MT

TD Cowen Downgrades Hims & Hers Health to Hold From Buy, Adjusts Price Target to $30 From $44
Apr. 29 MT
Logo Hims & Hers Health, Inc.

Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical records system, digital prescriptions and cloud-enabled pharmacy fulfillment. Its digital platform enables access to treatments for a range of conditions, including sexual health, men’s and women’s dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate. Through the Hims & Hers mobile applications, consumers can access a range of educational programs, wellness content, community support, and other services. It offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. It offers pharmacy operation capabilities through its MedisourceRx, a 503B outsourcing facility in California.

Employees

1,637


More about the company

Sell
Consensus

Buy

Mean consensus

HOLD

Number of Analysts

14

Last Close Price

41.88USD

Average target price

42.82USD

Spread / Average Target

+2.24%

Consensus

Quarterly revenue – Rate of surprise

  1. Stock Market
  2. Equities
  3. HIMS Stock
  4. News Hims & Hers Health, Inc.
  5. Hims & Hers Health Q1 Earnings, Revenue Rise

 

Search

RECENT PRESS RELEASES